00512.HK
Grand Pharmaceutical Group Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 4.31
−0.23%Year over year
Reported trailing growth
- Revenue
- +7.3%
- EBITDA
- -17.5%
- EBIT
- -0.7%
- EPS
- -45.7%
- Free cash flow
- -21.9%
- Operating cash flow
- -6.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +8.7%
- EBITDA
- -8.8%
- EBIT
- -25.5%
- Net income
- -15.8%
- EPS
- -16.0%
- Free cash flow
- +46.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026